Tlr9 Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABUS | B | Arbutus Biopharma Corporation | -0.37 | |
DVAX | D | Dynavax Technologies Corporation | 4.06 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | F | ETFMG Treatments Testing and Advancements ETF | 4.9 | |
FBT | D | First Trust Amex Biotech Index Fund | 2.89 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 2.74 | |
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 1.94 | |
PSCH | D | PowerShares S&P SmallCap Health Care Portfolio | 1.34 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 18 | ABUS | Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update |
- Tlr9
Toll-like receptor 9 is a protein that in humans is encoded by the TLR9 gene. TLR9 has also been designated as CD289 (cluster of differentiation 289). It is a member of the toll-like receptor (TLR) family. TLR9 is an important receptor expressed in immune system cells including dendritic cells, macrophages, natural killer cells, and other antigen presenting cells. TLR9 preferentially binds DNA present in bacteria and viruses, and triggers signaling cascades that lead to a pro-inflammatory cytokine response. Cancer, infection, and tissue damage can all modulate TLR9 expression and activation. TLR9 is also an important factor in autoimmune diseases, and there is active research into synthetic TLR9 agonists and antagonists that help regulate autoimmune inflammation.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles